Perioperative Chemotherapy Plus Cetuximab Versus Chemotherapy Alone for High Risk Resectable Colorectal Liver Metastasis
Clinical trial NCT03031444 · COMPLETED
Trial details
- NCT number
- NCT03031444
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2020-12-30
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.